Literature DB >> 3299819

A double-blind controlled trial of low dose acetylsalicylic acid and dipyridamole in the treatment of Raynaud's phenomenon.

J van der Meer, A A Wouda, C G Kallenberg, H Wesseling.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3299819

Source DB:  PubMed          Journal:  Vasa Suppl        ISSN: 0251-1029


× No keyword cloud information.
  9 in total

Review 1.  [Raynaud phenomenon in dermatology : Part 2: therapy].

Authors:  C Sunderkötter; G Riemekasten
Journal:  Hautarzt       Date:  2006-10       Impact factor: 0.751

Review 2.  Pathogenesis and treatment of Raynaud's phenomenon.

Authors:  J D Coffman
Journal:  Cardiovasc Drugs Ther       Date:  1990-01       Impact factor: 3.727

3.  [Primary and secondary Raynaud's phenomenon].

Authors:  J H W Distler
Journal:  Z Rheumatol       Date:  2008-05       Impact factor: 1.372

Review 4.  [Evidence-based therapy of Raynaud's syndrome].

Authors:  M Distler; J Distler; A Ciurea; D Kyburz; U Müller-Ladner; K Reich; O Distler
Journal:  Z Rheumatol       Date:  2006-07       Impact factor: 1.372

Review 5.  Management of Raynaud's phenomenon in systemic sclerosis-a practical approach.

Authors:  Andreu Fernández-Codina; Esperanza Cañas-Ruano; Janet E Pope
Journal:  J Scleroderma Relat Disord       Date:  2019-01-28

Review 6.  Management of Raynaud's phenomenon. Focus on newer treatments.

Authors:  S Roath
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

Review 7.  Vascular disease in scleroderma.

Authors:  Fredrick M Wigley
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

8.  Primary Raynaud's phenomenon in an infant: a case report and review of literature.

Authors:  Anjali A Sharathkumar; Paul Castillo-Caro
Journal:  Pediatr Rheumatol Online J       Date:  2011-07-18       Impact factor: 3.054

9.  Loss of digits after trauma in a patient with systemic lupus erythematosus.

Authors:  Heidee Villanueva; Marius Tijunelis; Sharon Shapiro; Sean O Henderson
Journal:  West J Emerg Med       Date:  2008-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.